Medicus Pharma Ltd. Announces Proposed Non-Brokered Private Placement of Common Shares and Conversion of Convertible Notes

Toronto, Ontario--(Newsfile Corp. - June 26, 2024) - Medicus Pharma Ltd. (TSXV: MDCX) (FSE: N46) (the "Company") is pleased to announce that it intends to complete a non-brokered private placement (th

newsfileJun 26 18:00 ET

Medicus Pharma Ltd. Announces Filing of Registration Statement for Proposed Initial Public...

Stockhouse May 29 07:00 ET

Medicus Pharma Ltd. Announces Closing of Private Placement of Convertible Notes

Yahoo FinanceMay 3 18:00 ET

Medicus Pharma Ltd. Announces Proposed Private Placement of Convertible Notes

Toronto, Ontario--(Newsfile Corp. - April 25, 2024) - Medicus Pharma Ltd. (TSXV: MDCX) (FSE: N46) (the "Company") is pleased to announce that it intends to complete the first closing of a private plac

newsfileApr 25 15:07 ET

Canadian Investment Regulatory Organization Trading Halt - MDCX

Stockhouse Apr 25 09:17 ET

Medicus Pharma Ltd. Receives FDA Comments on Phase 2 Clinical Protocol to Non-Invasively Treat Basal Cell Carcinoma of the Skin

FDA Agrees with the Study Design of Randomizing Up To 60 Participants with Nodular Type of Basal Cell CarcinomaToronto, Ontario--(Newsfile Corp. - March 21, 2024) - Medicus Pharma Ltd. (TSXV: MDCX) (F

newsfileMar 21 07:30 ET